These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18138747)

  • 21. [Value of 3-methyl-5, 5-phenyl-ethyl-hydantoin in therapy of epilepsy].
    HOLTZER PA
    Belg Tijdschr Geneesk; 1952 Sep; 8(18):817-31. PubMed ID: 13008950
    [No Abstract]   [Full Text] [Related]  

  • 22. Nuvarone (3-methyl-5, phenylhydantoin) in the treatment of epilepsy.
    TATERKA JH; THOMPSON CB
    Dis Nerv Syst; 1953 Apr; 14(4):108-10. PubMed ID: 13052037
    [No Abstract]   [Full Text] [Related]  

  • 23. [Benefits and adverse effects of methyl-phenyl-ethyl-hydantoin in the treatment of epilepsy].
    NEHLIL J
    Presse Med (1893); 1954 May; 62(36):760-1. PubMed ID: 13177463
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical evaluation of 1-methyl-5,5-phenyl-ethyl-hydantoin in the treatment of epilepsy.
    LIVINGSTON S; PAULI LL; KRAMER I; NAJMABADI A
    N Engl J Med; 1961 Aug; 265():418-21. PubMed ID: 13762831
    [No Abstract]   [Full Text] [Related]  

  • 25. [Our experiences in the treatment of epilepsy with methyl-phenyl-ethyl-hydantoin].
    ROGER J; ROGER A
    Prog Med (Paris); 1958 Feb; 86(4):67. PubMed ID: 13527523
    [No Abstract]   [Full Text] [Related]  

  • 26. Methyl hydantoin in the treatment of epilepsy.
    DAVID NA; DURKIN LS
    J Nerv Ment Dis; 1948 Aug; 108(2):118-28. PubMed ID: 18876440
    [No Abstract]   [Full Text] [Related]  

  • 27. Epilepsy; treatment with new drug; 3-methyl 5,5-phenyl-ethyl-hydantoin (phenantoin).
    KOZOL HL
    Am J Psychiatry; 1946 Sep; 103(2):154-8. PubMed ID: 21001983
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lymph node manifestations during methyl-phenyl-ethyl-hydantoin therapy].
    OLMER J; PAILLAS J; ROGER J; MURATORE R; BADIER M
    Presse Med (1893); 1952 Dec; 60(82):1748-50. PubMed ID: 13027182
    [No Abstract]   [Full Text] [Related]  

  • 29. [Medical significance of the hydantoins].
    SROKA K
    Klin Med Osterr Z Wiss Prakt Med; 1953 Apr; 8(4):171-8. PubMed ID: 13085651
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in the electroencephalogram following administration o mesantoin (methyl-phenyl-ethyl hydantoin).
    LITTLE SC; McAVOY M
    Electroencephalogr Clin Neurophysiol; 1949 Aug; 1(3):325-32. PubMed ID: 18135424
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiences with a new anti-epileptic drug: hydotin (3-methyl-5,5-diphenyl-hydantoin)].
    CASTELLUCCIO R
    Sem Med; 1952 Apr; 100(14):405-8. PubMed ID: 14942571
    [No Abstract]   [Full Text] [Related]  

  • 32. Mesantoin in the treatment of epilepsy; a study of its effect on the leukocyte count in seventy-nine cases.
    ABBOTT JA; SCHWAB RS
    N Engl J Med; 1954 Feb; 250(5):197-9. PubMed ID: 13119873
    [No Abstract]   [Full Text] [Related]  

  • 33. [The treatment of epilepsy with mesantoin].
    HALLEN O
    Munch Med Wochenschr; 1953 Aug; 95(34):913-4. PubMed ID: 13087111
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of epilepsy with mesantoin].
    HALLEN O
    Munch Med Wochenschr; 1953 Aug; 95(35):963-5; concl. PubMed ID: 13087132
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of epilepsy with anirrit].
    JANZ D
    Nervenarzt; 1953 May; 24(5):208-13. PubMed ID: 13099435
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of anirrit in the treatment of epilepsy.
    ROBINSON PK
    Br Med J; 1956 Jan; 1(4957):28. PubMed ID: 13269946
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of mesantoin therapy of epilepsy].
    KLOPP HW
    Med Monatsschr; 1951 Nov; 5(11):779-82. PubMed ID: 14910242
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of epilepsy with bagrosin-sodium].
    KOSLOWSKY HG
    Med Klin; 1957 Dec; 52(49):2128-9. PubMed ID: 13503578
    [No Abstract]   [Full Text] [Related]  

  • 39. [Complications in mesantoin therapy of epilepsy].
    ANDERSSON B
    Sven Lakartidn; 1953 Feb; 50(9):482-4. PubMed ID: 13077237
    [No Abstract]   [Full Text] [Related]  

  • 40. Central nervous action of hydantoins, oxazolidinediones and thiazolidones.
    CHEN G; ENSOR CR; CLARKE IG
    AMA Arch Neurol Psychiatry; 1951 Sep; 66(3):329-37. PubMed ID: 14867995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.